ARCHIVES

DCT Advisors OK Recompetition Of Drug Contacts

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Patient Care Emerges as Major Concern Following Sequestration Cuts to Medicare

April 5, 2013

Columbia Next for comprehensive Center Review

February 18, 1977

Sense Of Excitement, Challenges, Mark Healy’s Debut

April 26, 1991

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

October 25, 1985